Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neuroone Medical Technologies (NMTC) Short-term Investments (2022 - 2023)

Neuroone Medical Technologies' Short-term Investments history spans 2 years, with the latest figure at $995432.0 for Q1 2023.

  • For Q1 2023, Short-term Investments changed N/A year-over-year to $995432.0; the TTM value through Mar 2023 reached $995432.0, changed N/A, while the annual FY2022 figure was $3.0 million, N/A changed from the prior year.
  • Short-term Investments reached $995432.0 in Q1 2023 per NMTC's latest filing, down from $3.0 million in the prior quarter.
  • In the past five years, Short-term Investments ranged from a high of $3.0 million in Q3 2022 to a low of $995432.0 in Q1 2023.